Signature »

Arrivent Biopharma shares owned by Signature

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Signature from 13F filings

Historical chart of Signature investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Signature

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8k 368 18.45
2025-06-30 $392 18 21.78

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Malvern Fds Core Bd Etf (VCRB)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr National Mun Etf (MUB)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma